Transfixed by transgenics: how pathology assumptions are slowing progress in Alzheimer's disease and related dementia research
Abstract Model organisms of human diseases are invaluable tools for unraveling pathogenic mechanisms, identifying potential targets for drug development, and evaluating the therapeutic efficacy of candidates in preclinical trials. The utility of model organisms hinges upon their ability to faithfull...
Saved in:
| Main Author: | Luciano D'Adamio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2023-09-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.202318479 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The intracellular threonine of amyloid precursor protein that is essential for docking of Pin1 is dispensable for developmental function.
by: Alessia P M Barbagallo, et al.
Published: (2011-03-01) -
Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo.
by: Alessia P M Barbagallo, et al.
Published: (2010-11-01) -
Murine Non-Transgenic Models of Alzheimer’s Disease Pathology: Focus on Risk Factors
by: Maricarmen Hernández-Rodríguez, et al.
Published: (2025-03-01) -
Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseases
by: Tao Yin, et al.
Published: (2025-12-01) -
Evaluating the safety and feasibility of remote ischemic conditioning for slowing cognitive decline in mild Alzheimer’s dementia
by: Xin Huang, et al.
Published: (2025-06-01)